Navigation Links
FDA chief takes decision without two senior officials’ opinion

In a crucial decision taken to delay action on Barr Pharmaceuticals Inc.’s 'morning-after' contraceptive the FDA chief did not take two senior officials opinion.// The FDA is in thick smoke as it has been sued by the non-profit Center for Reproductive Rights saying science was influenced by politics.

Director of the FDA’s Center for Drug Evaluation and Research, Dr. Steven Galson, admitted that he wanted to approve the drug. Still, in Galson’s words, “then Acting FDA Commissioner Lester Crawford told me that he was concerned about where we were heading because he knew that I was heading towards this recommendation, and he told me that he was going to make the decision on what to do with the application.”

A set of pills that can prevent pregnancy if taken within 72 hours of sexual intercourse is what the drug is all about.

The acting chief then, Crawford was confirmed as permanent FDA commissioner in July 2005. Thereafter this delay was announced.

This is the bone of contention and can land him in trouble.
'"/>




Page: 1

Related medicine news :

1. EU medical chief says Europe ready for bird flu
2. Making Budhia run 65 km absolutely cruel,says Infosys chief
3. A&E departments To Be Shut Down warns NHS chief
4. NHS acting chief’s intervie
5. Mittal tightens grip on steel making giant, to be its chief
6. India takes on foot-and-mouth disease by vaccinating animals
7. Roller coaster takes brain for a big ride!!
8. Children! Protecting them from medical mistakes
9. Men who takes risk is unlikely to impress women
10. Research on HIV takes new direction
11. Anorexia nervosa takes its toll on life!!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive Heath,” hits ... proof that attitude and determination can combine into the most remarkable achievements. Over ... holidays. This campaign will offer patients a new-found hope, by seizing the opportunity ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic imaging ... Heart at their tradeshow booth # 941 for the American Association of Equine ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 Lianluo Smart Limited ... "the Company") which develops, markets and sells medical ... China and international markets, recently ... and Treatment New Progress Forum, co-hosted by the ... Province , Guangdong Provincial People,s Hospital and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology: